Patents by Inventor George Daniel Demetri

George Daniel Demetri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8119638
    Abstract: Et 743 is used in the preparation of a medicament for the treatment of the human body for cancer.
    Type: Grant
    Filed: June 28, 2007
    Date of Patent: February 21, 2012
    Assignee: Pharma Mar, S.A.
    Inventors: Esteban Cvitkovich, George Daniel Demetri, Cecilia Guzman, Jose Jimeno, Luis Lopez Lazaro, Jean Louis Misset, Chris Twelves, Daniel D. Von Hoff
  • Patent number: 6958335
    Abstract: 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula I or a pharmaceutically acceptable salt thereof can be used in the treatment of gastrointestinal stromal tumours.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: October 25, 2005
    Assignees: Novartis AG, Dana-Farber Cancer Institute, Inc., Oregon Health & Science University
    Inventors: Elisabeth Buchdunger, Renaud Capdeville, George Daniel Demetri, Sasa Dimitrijevic, Brian Jay Druker, Jonathan A. Fletcher, Michael C. Heinrich, Heikki Joensuu, Sandra Leta Silberman, David Tuveson
  • Publication number: 20040023976
    Abstract: 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the formula (I) or a pharmaceutically acceptable salt thereof can be used in the treatment of gastrointestinal stromal tumours.
    Type: Application
    Filed: August 11, 2003
    Publication date: February 5, 2004
    Inventors: Elisabeth Buchdunger, Renaud Capdeville, George Daniel Demetri, Sasa Dimitrijevic, Brian Jay Druker, Jonathan A. Fletcher, Michael C. Heinrich, Heikki Joensuu, Sandra Leta Silberman, David Tuveson